Resmed (RMD) Other Operating Expenses (2009 - 2026)

Resmed (RMD) has 18 years of Other Operating Expenses data on file, last reported at $11.2 million in Q1 2026.

• For the quarter ending Q1 2026, Other Operating Expenses rose 3.23% year-over-year to $11.2 million; the trailing twelve-month figure through Mar 2026 stood at $46.9 million (up 5.29% YoY), and the FY2023 full-year result was $20.2 million, changed N/A from the prior year.
• Other Operating Expenses for Q1 2026 stood at $11.2 million, down from $11.8 million in the prior quarter.
• Across five years, Other Operating Expenses topped out at $75.8 million in Q4 2023 and bottomed at $7.7 million in Q1 2022.
• The 5-year median for Other Operating Expenses is $11.4 million (2024), against an average of $15.3 million.
• The widest annual swing landed in 2023, when Other Operating Expenses jumped 321.72%; it then slumped 85.43% in 2024.
• A 5-year view of Other Operating Expenses shows it stood at $18.0 million in 2022, then surged by 321.72% to $75.8 million in 2023, then plunged by 85.43% to $11.0 million in 2024, then rose by 6.81% to $11.8 million in 2025, then fell by 4.68% to $11.2 million in 2026.
• The last three Other Operating Expenses figures came in at $11.2 million (Q1 2026), $11.8 million (Q4 2025), and $12.0 million (Q3 2025), per Business Quant data.

Peer Comparison